Back to search
FDAFDA · Food and drugs·Recall number Z-0501-2015

MAS CardioImmune XL Cardiac Marker Control; Model: CAI-XL1; intended for use in the clinical laboratory as an assayed control serum for monitoring assay conditions in specific cardiac marker determinations.

Published December 10, 2014 · Recall initiated: October 20, 2014

Summary

FDA records medical device Class II recall Z-0501-2015, published December 10, 2014 and initiated October 20, 2014. Recalling firm: Microgenics Corporation; Status: Terminated; Reported quantity: 2135 vials.; Lot: Model No.: CAI-XL1; Lot Number: CXL16011, Exp. Date: 2016-01-31. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Microgenics Corporation
Distributor
Worldwide Distribution - USA (nationwide) including Puerto Rico and the states of AR, AZ, CA CO, CT, DE, FL GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI and WY., and the countries of Australia, Canada, China, Germany, Guam, Hong Kong and Taiwan.
Lot
Model No.: CAI-XL1; Lot Number: CXL16011, Exp. Date: 2016-01-31.
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was MAS CardioImmune XL Cardiac Marker Control; Model: CAI-XL1; intended for use in the clinical laboratory as an assayed control serum for monitoring assay conditions in specific cardiac marker determinations. recalled?

Yes. FDA published recall Z-0501-2015 on December 10, 2014. Reported hazard: MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).

What should I do if I have this product?

Voluntary: Firm initiated · Letter